Merck
MRK
#46
Rank
โ‚น28.129 T
Marketcap
โ‚น11,262
Share price
1.28%
Change (1 day)
45.27%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): โ‚น637.91

According to Merck's latest financial reports the company's current EPS (TTM) is โ‚น664.56. an increase over its 2024 EPS that were of โ‚น614.76.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025โ‚น662.137.71%
2024โ‚น614.764308.46%
2023โ‚น13.95-97.32%
2022โ‚น521.1510.92%
2021โ‚น469.8584.68%
2020โ‚น254.42-27.2%
2019โ‚น349.4663.44%
2018โ‚น213.81151.11%
2017โ‚น85.15-54.58%
2016โ‚น187.4530.21%
2015โ‚น143.96-61.99%
2014โ‚น378.70180.51%
2013โ‚น135.00-31.82%
2012โ‚น198.006.62%
2011โ‚น185.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,013 52.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น669.41 0.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น123.69-81.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น340.97-48.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,094 215.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,303 96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น187.83-71.74%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น270.13-59.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น342.71-48.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น112.78-83.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel